Phase I Dose-Escalation Trial of Stereotactic Ablative Body Radiotherapy (SAbR) for Men with High-Risk Prostate Cancer

Category Primary study
JournalInternational Journal of Radiation Oncology Biology Physics
Year 2020
This article has no abstract
Epistemonikos ID: e8a17af037dba02a0cd0e7b6b46784525fe8ea03
First added on: Feb 12, 2025